Full name
CENTRUM BADAŃ KLINICZNYCH PI-HOUSE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
58.11.Z - Publishing of books
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
86.2 - Medical and dental practices
86.90 - Other healthcare activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | 0,2 | -0 | -100,1 |
EBITDA | 0,4 | 0,3 | 0,2 | -49,4 |
Short time liabilities | 1 | 0,6 | 0,7 | 6,8 |
Equity capital | 1 | 1,2 | 1,2 | -5,4 |
Operating profit (EBIT) | 0,2 | 0,2 | 0,1 | -73,2 |
Assets | 2,7 | 2,9 | 3,1 | 6,7 |
Net profit (loss) | 0,2 | 0,2 | -0 | -102,8 |
Cash | 1,2 | 0,4 | 0,5 | 25,9 |
Net income from sale | 8,9 | 9,5 | 11,7 | 22,5 |
Liabilities and provisions for liabilities | 1,7 | 1,7 | 2 | 15,5 |
Working assets | 2,3 | 2,5 | 2,4 | -2,2 |
Depreciation | 0,1 | 0,1 | 0,1 | 3,6 |
% | % | % | p.p. | |
Profitability of capital | 16,4 | 20 | -0,6 | -20,6 |
Equity capital to total assets | 36,1 | 41,9 | 37,1 | -4,8 |
Gross profit margin | 2,5 | 2,6 | -0 | -2,6 |
EBITDA Margin | 4 | 3,6 | 1,5 | -2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 24 | 21 | -3 |
Current financial liquidity indicator | 1.363713026046753 | 1.447351098060608 | 1.2257513999938965 | -0,2 |
Net dept to EBITDA | -3.0709285736083984 | -1.1630090475082397 | -3.1382670402526855 | -1,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane